Latest News and Press Releases
Want to stay updated on the latest news?
-
STOCKHOLM, Sweden, August 15, 2003 (PRIMEZONE) -- Getinge AB (Other OTC:GNGBF) has today signed a binding agreement for the acquisition of Siemens LSS (Life Support Systems). The acquisition is...
-
STOCKHOLM, Sweden, July 14, 2003 (PRIMEZONE) -- Getinge: -- Orders received amounted SEK 4,202.1 million (4,355.9) -- Net sales amounted to SEK 4,140.6 million (3,987.4) -- The profit before...
-
STOCKHOLM, Sweden, June 24, 2003 (PRIMEZONE) -- Today Getinge (Other OTC:GNGBF) announces that German competition authorities (Bundeskartellamt) have approved the acquisition of the Jostra group. The...
-
STOCKHOLM, Sweden, May 22, 2003 (PRIMEZONE) -- Getinge (Other OTC:GNGBF) continues its expansion within Surgical Systems entering the cardiopulmonary market. Getinge has acquired 100% of the shares...
-
STOCKHOLM, Sweden, April 23, 2003 (PRIMEZONE) -- Getinge (Other OTC:GNGBF) - Orders received totalled SEK 2,165.4 million (2,167.6) - Invoicing totalled SEK 2,003.0 million (1,909.2) - The...
-
STOCKHOLM, Sweden, March 31, 2003 (PRIMEZONE) -- Getinge (Other OTC:GNGBF) today acquired all shares of Dutch company Copharm B.V. Copharm has been business area Surgical Systems' agent on the...
-
STOCKHOLM, Sweden, Jan. 27, 2003 (PRIMEZONE) -- Getinge AB (Other OTC:GNGBF): FINANCIAL STATEMENT 2002 -- The profit before tax climbed by 25% in Q4 to SEK 405.0 million (324.6 m) -- The...
-
STOCKHOLM, Sweden, Oct. 17, 2002 (PRIMEZONE) -- Getinge: - Profit before tax rose by 30% to 146.0 SEK million (112.3) in Q3, including WSP costs of SEK 25 million - Cash flow continued to be...
-
STOCKHOLM, Sweden, Oct. 15, 2002 (PRIMEZONE) -- In line with previous announcements, Getinge (Other OTC:GNGBF) has signed an agreement to sell ALM's surgical tables business. The sale of the surgical...
-
STOCKHOLM, Sweden, Sept. 13, 2002 (PRIMEZONE) -- Getinge has today informed employees and union representatives at the Heraeus Med factory in Hanau Germany, that the company intends to discontinue...